These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
574 related items for PubMed ID: 15350333
1. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b. Boehm MD, Huang AJ. Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333 [Abstract] [Full Text] [Related]
2. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up. Krilis M, Tsang H, Coroneo M. Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834 [Abstract] [Full Text] [Related]
3. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia. Vann RR, Karp CL. Ophthalmology; 1999 Jan; 106(1):91-7. PubMed ID: 9917787 [Abstract] [Full Text] [Related]
4. Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Schechter BA, Schrier A, Nagler RS, Smith EF, Velasquez GE. Cornea; 2002 Jan; 21(1):6-11. PubMed ID: 11805499 [Abstract] [Full Text] [Related]
5. Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b. Schechter BA, Koreishi AF, Karp CL, Feuer W. Ophthalmology; 2008 Aug; 115(8):1291-6, 1296.e1. PubMed ID: 18187195 [Abstract] [Full Text] [Related]
6. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Karp CL, Moore JK, Rosa RH. Ophthalmology; 2001 Jun; 108(6):1093-8. PubMed ID: 11382635 [Abstract] [Full Text] [Related]
7. Topical Interferon α-2b as a Single Therapy for Primary Ocular Surface Squamous Neoplasia. Kusumesh R, Ambastha A, Sinha B, Kumar R. Asia Pac J Ophthalmol (Phila); 2015 Jun; 4(5):279-82. PubMed ID: 26176194 [Abstract] [Full Text] [Related]
10. Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification. Shah SU, Kaliki S, Kim HJ, Lally SE, Shields JA, Shields CL. Arch Ophthalmol; 2012 Feb; 130(2):159-64. PubMed ID: 22332208 [Abstract] [Full Text] [Related]
12. Safety and efficacy of topical interferon alpha 2B and mitomycin C for localized conjunctival intraepithelial neoplasia: long-term report of their pharmacological safety and efficacy. Alvarado-Castillo B, Santa Cruz-Pavlovich FJ, Gonzalez-Castillo C, Vidal-Paredes IA, Garcia-Benavides L, Rosales-Gradilla ME, Navarro-Partida J. BMC Ophthalmol; 2023 Jul 27; 23(1):335. PubMed ID: 37501105 [Abstract] [Full Text] [Related]
13. Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction. Kim HJ, Shields CL, Shah SU, Kaliki S, Lally SE. Ophthalmology; 2012 May 27; 119(5):938-44. PubMed ID: 22361315 [Abstract] [Full Text] [Related]
14. [Topical interferon alfa-2b for primary treatment of conjunctiva-cornea intraepithelial neoplasia]. Pérez de Arcelus M, Aranguren M, Andonegui J. An Sist Sanit Navar; 2012 May 27; 35(1):137-41. PubMed ID: 22552136 [Abstract] [Full Text] [Related]
17. 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. Yeatts RP, Engelbrecht NE, Curry CD, Ford JG, Walter KA. Ophthalmology; 2000 Dec 27; 107(12):2190-5. PubMed ID: 11097594 [Abstract] [Full Text] [Related]